Corrigendum to "In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19" [Infection, Genetics and Evolution 103 (2022) 105318]
1 Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran; Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
2 Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran; Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran. Electronic address: kiabiotpro@yahoo.com.
3 Department of Molecular Medicine, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
4 Vista Aria Rena Gene Inc., 4913817644 Gorgan, Iran.
5 Cellular and Molecular Research Center, Research Institute for prevention of Non-Communicable Disease, Qazvin University of Medical Sciences, Qazvin, Iran.
6 Department of Medical Nanotechnology, School of Advanced technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
7 Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan, Iran.